ADMS

Adamas Pharmaceuticals, Inc.

ADMS

Delisted

ADMS was delisted on the 23rd of November, 2021.

77 hedge funds and large institutions have $276M invested in Adamas Pharmaceuticals, Inc. in 2017 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 29 reducing their positions, and 3 closing their positions.

New

Increased

Maintained

Reduced

Closed

2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q3 2017 Q2 2017 Q1 2016 Q4 2016 Q3 2016 Q2 2016 Q1 2015 Q4 2015 Q3 2015 Q2 2015 Q1 2014 Q4 2014 Q3 2014 Q2

Holders

Holders Change

Holders Change %

+10%

% of All Funds

1.92%

Holding in Top 10

Holding in Top 10 Change

–

Holding in Top 10 Change %

–

% of All Funds

0.07%

New

Increased

Reduced

Closed

Calls

$453K

Puts

$478K

Net Calls

-$25K

Net Calls Change

+$383K

Top Buyers

1	AC Armistice Capital New York	$20.3M
2	BWCA Brenner West Capital Advisors New York	$24.8M
3	RPAM Rhenman & Partners Asset Management Stockholm, Sweden	$6.44M
4	AI Axiom Investors Greenwich, Connecticut	$1.77M
5	Point72 Asset Management Stamford, Connecticut	$2.01M

Top Sellers

1	GPP Great Point Partners Greenwich, Connecticut	$38.8M
2	OTPPB Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada	$4.33M
3	PVI Pura Vida Investments New York	$1.38M
4	JPMorgan Chase & Co New York	$18K
5	BlackRock New York	$20.8M

#	Name	Holding	Trade Value	Shares Change	Shares Change %
26	26 State of Wisconsin Investment Board Madison, Wisconsin	$1.94M	+$192K	+11,000	+11%
27	CCMU 27 Cheyne Capital Management (UK) London, United Kingdom	$1.9M	-$104K	-5,928	-5%
28	PPA 28 Parametric Portfolio Associates Seattle, Washington	$1.9M	-$53.8K	-3,079	-3%
29	29 BAMCO Inc New York	$1.81M	+$564K	+32,272	+45%
30	AI 30 Axiom Investors Greenwich, Connecticut	$1.77M	+$1.77M	+100,912	New
31	31 State of New Jersey Common Pension Fund D Trenton, New Jersey	$1.64M	–	–	–
32	PVI 32 Pura Vida Investments New York	$1.38M	-$2.77M	-158,397	-67%
33	33 Bank of New York Mellon New York	$1.11M	-$43.6K	-2,493	-4%
34	34 Goldman Sachs New York	$996K	-$69.2K	-3,958	-6%
35	35 Allianz Asset Management Munich, Germany	$950K	-$19.9K	-1,139	-2%
36	TCIM 36 TIAA CREF Investment Management New York	$788K	-$16.4K	-935	-2%
37	37 Citadel Advisors Miami, Florida	$606K	+$606K	+34,628	New
38	PAM 38 Private Asset Management San Diego, California	$595K	–	–	–
39	OPPM 39 Opus Point Partners Management New York	$525K	-$525K	-30,000	-50%
40	40 Charles Schwab San Francisco, California	$481K	–	–	–
41	41 Morgan Stanley New York	$472K	-$57.7K	-3,308	-11%
42	TA 42 Teachers Advisors New York	$468K	-$29.1K	-1,666	-6%
43	43 Susquehanna International Group Bala Cynwyd, Pennsylvania	$463K	+$463K	+26,472	New
44	44 California State Teachers Retirement System (CalSTRS) West Sacramento, California	$453K	-$122K	-7,000	-21%
45	AA 45 ALPS Advisors Denver, Colorado	$353K	+$22.2K	+1,272	+7%
46	GH 46 GAM Holding Zurich, Switzerland	$350K	–	–	–
47	47 New York State Common Retirement Fund Albany, New York	$317K	-$18	-1	-0%
48	48 Deutsche Bank Frankfurt Am Main Ge, Germany	$315K	+$226K	+12,982	+254%
49	49 RhumbLine Advisers Boston, Massachusetts	$300K	-$40.4K	-2,309	-12%
50	AAP 50 Ardsley Advisory Partners Stamford, Connecticut	$262K	–	–	–

Adamas Pharmaceuticals, Inc. ADMS

Top Buyers

Top Sellers

Adamas Pharmaceuticals, Inc.

ADMS